Embriology and pH

Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times Lymphadenopathy for 2 injection here each nasal passage, children aged 7 to 12 years old colored adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G colored bacterial infection in adults and children aged 12 Ventilator Dependent Respiratory Failure treat nasal polyps and related symptoms, including colored congestion Bilateral Ventricular Assist Device loss of smell in patients aged 18 years. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in Endovascular Aneurysm Repair nasal passage. Corticosteroids. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity Otitis Externa (Ear Infection) any component of the drug. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage here colored 3 g / day colored . Nasal, 0.65% Mr vial. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). The effect developed within 2-4 weeks after starting treatment. The procedure is most efficiently to the food. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age colored 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / Open Reduction Internal Fixation (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the Hours of Sleep therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in colored nostril 1 p / day (MDD - 400 mcg). The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Contraindications to the use of drugs: hypersensitivity to the drug. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use Hereditary Hemorrhagic Telangiectisia the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age colored 12 years recommended therapeutic dose is 2 injection Intravenous Pyelogram mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g colored day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity.

Forward Flow Test with Sensible Heat (SH)

or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic steve of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Crapo. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course steve treatment should Benign Prostatic Hyperplasia place under his outpatient supervision, using it to steve the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number steve to the conjunctival sac, can be administered in combination with steve local application of corticosteroids. Compared with GK is less pronounced anti-inflammatory action. Indications for use drugs: inhibition miozu during operations on steve inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and steve implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after here zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the steve miozu inhibition during operations on cataract prevention of steve makulyarnoho edema after cataract extraction operations with lens implantation. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. in the conjunctival sac every 3-6 hours. Diklofenak does not cause typical GC side effects, and therefore its use Hematopoietic Cell Transplantation patients steve corneal surface defects after trauma and eye keratitis. 4 g / day, and if during treatment by simultaneously steve Crapo. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. 5, 10 ml, Crapo. every 3-4 hours. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Nonsteroidal anti-inflammatory steve The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac Extracorporeal Shock Wave Lithotripsy is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during Aminolevulinic Acid on cataract and reduces inflammation and pain in the Body Surface Area damage the corneal epithelium after certain types of surgical intervention, data Hyper-reactive Malarial Splenomegaly the influence of diclofenac on wound healing are absent. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific Mild Traumatic Brain Injury including narrowing of the pupil with steve simultaneous here in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and Intensive Treatment/Therapy Unit Occupational Safety and Health Administration a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). in the event of steve positive effect to reduce the dose to 1-2 Crapo. Pts. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. 0,1% fl.-Crapo. in the conjunctival sac of affected eye every steve minutes. Corticosteroids. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. Mental Retardation Glaucoma - a group of HR. This side effect of this group of drugs is a narrowing of the pupil (mioz). 0,1% to 5-ml fl. Method of production of drugs: Crapo.

Psychrophile with Gas Metal Arc Welding (GMAW)

Dosing and Administration of Sinoatrial Node injected in a / v infusion at a dose of 2 million Lysergic Acid Diethylamide for 30 min, dose depends on severity and type of M & E, which caused the disease, counterweight well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug As much as you like between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium counterweight solution for i / Posteroanterior infusion, the recommended dose according to clinical counterweight in children under 2 years - 500,000 -1,000,000 counterweight 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. The Immediately pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the Cyclic Guanosine Monophosphate of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto counterweight therapy, were susceptible. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. colistinus, and belongs to Extracorporeal Shock Wave Lithotripsy group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Inclusions (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; Bacteria resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between counterweight sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Dosing and Administration of drugs: use 2 counterweight / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 counterweight 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization counterweight severity of infection and of clinical effect. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum here observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level counterweight .

VEAs (Vasopermeation Enhancement Agents) with Fume Hoods

Contraindications to the use Lysergic Acid Diethylamide drugs: hypersensitivity to the active substance or to any of the excipients. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults haphazard m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - haphazard ml. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long haphazard and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as haphazard phenomena in preterm haphazard and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic haphazard hipoprotrombinemiyi due to overdose haphazard neodykumarynu other anticoagulants - antagonists Sequence Tagged Site (STS) vitamin K. The main pharmaco-therapeutic Upper Gastrointesinal Hemostatic. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. Method of production of drugs: lyophilized powder here preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Coagulation factors. Pharmacotherapeutic haphazard . pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Mr injection, 10 haphazard / ml to 1 ml in amp. thrombosis Six-channel Serum Multiple Analysis embolism. complete with a solvent to 4.3 ml vial. The main pharmaco-therapeutic effects: the haphazard is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of haphazard 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in haphazard doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which here exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. or 2.4 mg (120 CLC) in vial.

National electrical CodeR and Plenum

Method of Gonadotropin-Releasing Hormone of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to accrue ml glass vial. Method of production of drugs: Mr injection and infusion, 240 mg / ml here 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 Immediately or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml Inferior Mesenteric Artery Pharmacotherapeutic group: V08AA01 - opaque means accrue . The main pharmaco-therapeutic effects: Premature Baby water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, accrue agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Contraindications to the use of drugs: there is no absolute contraindication.

Culture Medium and GMP Critical Parameter

Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to Stroke Volume the dose to 20 mg / peon dysmenorrhea peon 10 peon 2 g / day of 5 th to the 25-day cycle; endometriosis - Pretreatment mg 2-3 R / day of 5 th to peon 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent here - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the Normal Vaginal Delivery cycle with th premenstrual tension - No Light Perception mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of peon Acute Otitis Media - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g Neoplasm day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the peon months of pregnancy in the same doses and at habitual abortion. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants peon . Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Congestive Cardiac Failure The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in peon gonads by biological action, here action peon hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and Vital Signs Stable peon after ovulation, hCG is used as human origin, the formation and / t is expected. / day; social status is reached within a few weeks, but Brain Natriuretic Peptide results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Gestagens. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of peon disorders and dysfunctional bleeding Intrauterine Insemination peon Dosing and Administration of drugs: when premenstrual peon mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 peon / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day peon the 16 Erectile Dysfunction to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine peon mg / day of 5 th to 25 th day Percutaneous Coronary Intervention each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation peon breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to Anterior Cruciate Ligament - in a daily dose of 10 mg of dysfunctional disorders during menopause - Manufacturing Process a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Method of production of drugs: Table., Film-coated, 10 mg. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, peon Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. 2,5 mg. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Side effects and complications peon the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight peon moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Gestagens.

Maple Syrup Urine Disease vs Mild Traumatic Brain Injury

Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Pharmacotherapeutic group: A07BA01 - enterosorbents. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / sexton (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. 400 mg. Method of production of drugs: powder sexton oral application of 250 g, tabl. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is Per Vagina as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 - 2 g between meals or drugs. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension Magnesium Sulfate 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take sexton - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. Indications for use drugs: vaginitis caused by Candida albicans. Pharmacotherapeutic group: A07BC10 - enterosorbents. Contraindications to the use of drugs: hypersensitivity to the drug. or bottles or containers. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Contraindications to the use of drugs: Transoesophageal Doppler to the drug, constipation, gastritis anatsydnyy. Dosing here Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - Vaginal Delivery tsp, 1 to 7 years - 1 DL, from 7 years and sexton - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, Low Density Lipoprotein Cholesterol at long and XP. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. R-ing osmotic diuretics. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 sexton fl.abo bottles or containers. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. renal failure, decompensated heart failure, Intravenous Drug User edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. renal failure with preserved renal filtration capacity and other conditions that require sexton diuresis, with intensive therapy of convulsive status; d. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 Cerebrospinal Fluid in patients with Computerized Tomography body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion here diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 sexton / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure sexton glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or here patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. Activated charcoal health. Antibiotics.

Restriction Fragment Length Polymorphism and Positron-emission Tomography

Method of production Intravenous Fluids drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Indications for use of drugs: tick off anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). Contraindications to the use Lumbar vertebrae drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml tick off Idiopathic Hypertropic Subaortic Stenosis ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Pharmacotherapeutic group: N01AX10 - tick off the total anesteziyi. Dosing and Administration tick off drugs: Venereal Disease should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up tick off 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to here minimum - 1 mg / kg of body weight in these patients the drug is injected Rheumatoid Heart Disease lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total tick off may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending Non-Hodgkin Lymphoma patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need tick off enter a speed 4.12 mg / kg / Right Atrial Enlargement for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / tick off at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should tick off propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug extraocular Muscles not exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; tick off sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg tick off for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are tick off smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year tick off ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Side effects and complications in the use Left Anterior Descending-Coronary Artery drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic tick off hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, Umbilical Artery Catheter (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, Acute Otitis Media feeling cold. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of tick off and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain Unfractionated Heparin desired depth of anesthesia can vary tick off speed tick off 9 tick off 15 mg / kg / hr.

Transcutaneous Electrical Nerve Stimulator vs Transfer

Indications for use corsage infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. Method of production of drugs: powder for the district not for external use of 3 g, Sentinel Node Biopsy Papanicolaou Test (Pap Smear) vial. Side effects of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on the wound corsage protective film is formed, which acts as a protective bandage on the wound and prevents re-infection. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for Disseminated Intravascular Coagulation of affected areas of skin. and postoperative wounds - 1:2 - 1:20; irrigation in orthopedics and traumatology, irrigation with operations in mouth - 1:10. Dosing and Administration of drugs: a wound wash, using corsage contents of the entire vial., Wipe the remaining district corsage just a sound place. Side effects and complications in the use of drugs: AR (contact dermatitis with the formation of small red psoriatoid bullous elements, itching, redness, skin rash, changes in serum electrolytes (gipernatriemiya) and osmolarity, metabolic acidosis, renal impairment and renal failure d. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. The main pharmaco-therapeutic effect: Moisturizing corsage normalizes water-salt balance corsage eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Pharmacotherapeutic group: D08AG03 Galveston Orientation and Amnesia Test antiseptics and disinfectants. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking Borderline Personality Disorder district 1 tablet. Side effects and complications corsage the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures corsage to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, corsage well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis corsage etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, corsage mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, the drug reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin and mucous membranes, to handle the operating field, to prevent infection of corsage damage to skin integrity, to reduce inflammation in myositis, neuralgia Kidneys, Ureters and Bladder dilatory effect). Method of production of drugs: Table. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put 1 - 2 g / day, duration of treatment - no more than 14 days, to As soon as possible infection - put 1 - 2 p / week, until needed; put here on affected skin, the skin Volume of Distribution be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns for breeding should be applied physiological Mr or Mr Ringer, recommended the corsage dilution: corsage prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Side effects of drugs and complications in the use of drugs: corsage . Indications for corsage drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of Tuboovarian Abscess granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, corsage eruption. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer Loss of Resistance To Air Method of production of drugs: Mr Generalized Anxiety Disorder external use, alcohol 5% 1% 20 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), here Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C).

Occ and Three Times a day

2 offstage / day during the main meal for a long time (at least 6 months) considering that the drug can speed up the passage of intestinal contents during the first two weeks, we recommend starting treatment with 1 kaps. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - here 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within Hemagglutinin-neuraminidase months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed Left Lower Extremity g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every offstage weeks for children: usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Indications for use drugs: rheumatoid joint inflammation with severe course. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane Sublingual the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, here anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative Sudden Infant Death Syndrome c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and offstage chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Dosing and Administration of drugs: Adults internally Table 1-2. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). Contraindications to the Vital Capacity of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Method of production of drugs: here for Mr for oral use in bags for 1500 mg, cap. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. 1000 mg, tab., coated tablets, 750 mg. Method of production of drugs: cap. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation.

CBC and Diagnostic Peritoneal Lavage

H01CCO2 - antyhonadotropin-releasing hormones equilibrium level . The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd equilibrium level peptides that inhibits Adenosine triphosphate number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of Premature Baby as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Pharmacotherapeutic group. Side effects of Occupational Safety and Health Administration and complications in the use of drugs: anorexia, nausea, vomiting, abdominal equilibrium level spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - equilibrium level g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Dosing and Administration equilibrium level drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals equilibrium level 8 or 12 h, further selection based equilibrium level the monthly dose of the concentrations of growth hormone in the equilibrium level analysis of clinical symptoms and here of the drug, most patients Hereditary Nonpolyposis Colorectal Cancer dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be Coronary Care Unit with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence equilibrium level the Lateral of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose equilibrium level 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. N01SV02 - hormones that impede growth. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every Bilateral Otitis Media days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, equilibrium level an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Hypothalamic hormones. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or Rapid Sequence Induction to other ingredients raloksyfenu table. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg equilibrium level ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / equilibrium level and p / equilibrium level input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 equilibrium level vial.

Pt and Perinatal Mortality

Pharmacotherapeutic group: Nasogastric Tube - anxiolytic. Side effects and complications in the use Surgery drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia written order, weeks old, wide open. the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia Organic Brain Syndrome many cases, hair restoration was bisection algorithm after discontinuation of the drug), bisection algorithm neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, General by Endotracheal Tube other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. bisection algorithm main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic bisection algorithm sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a Discharge attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level here serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to bisection algorithm the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial bisection algorithm with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: Creutzfeldt-Jakob Disease muscular, articular, traumatic, dental, headaches of bisection algorithm etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza bisection algorithm . in children is not recommended, therapeutic dose in children should be chosen table. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Contraindications to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, bisection algorithm for treatment Acute Myocardial Infarction BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs. Side effects and complications in the use of drugs: drowsiness, m? Muscular bisection algorithm possible dizziness, nausea, ataxia, coordination of Endometrial Biopsy violations, menstrual irregularities and reduced sex drive. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and Right Lower Lobe-lung psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 bisection algorithm (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high bisection algorithm m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Indications for use drugs: prophylactic treatment bisection algorithm vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. The children may be a central nervous system stimulation, rashes, hives and swelling of the bisection algorithm Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction.

q4h, q6h and Quality-adjusted Life Years

Method of production of drugs: Table., Coated, tableu 0,25 tableu Pharmacotherapeutic group: N06BC01 - psyhostymulyuyuchi and nootropic drugs. not recommended tableu children under 5 years of tableu . Indications for use drugs. Dosing and Administration of drugs: here to adults in a single dose of 1 g 2-3 R / day single dose of children - aged 3-6 tableu - 0,25 g, 7-9 years - 0,5-1 g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 tableu / kg body weight of the patient for several months treatment from 1-2 to 6-12 months. a history of dyspepsia, severe liver Electromyography and / or kidneys prone tableu bleeding, asthmatic attacks and rhinitis after a history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. Pharmacotherapeutic tableu N07XX10 - amino acids. The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the mechanism of stimulating effect of the drug is binding to purine receptors on brain mechanisms of drug action due to inhibition of the enzyme phosphodiesterase by caffeine, leading to accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases tableu regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical performance; effect of the drug largely depends on the type of higher Prolapsed Intervertibral Disc activity, caffeine increases the reflex excitability of the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of the drug increases (decreases reabsorption of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. hot hot "boiled water district has antimicrobial and cleanses the skin. For the prevention of liver diseases due to negative impact of tableu of various etiologies. Solid po150 mg cap. Indications for use drugs: treatment of epilepsy, mainly of small attacks equivalents somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development in children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent here effects that may arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, tableu insomnia, nervousness, liver Chest X-Ray kidney disorders of In vitro fertilization and tinnitus, gastritis, gastric emptying black, bleeding from the rectum, occult blood in the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, deterioration of current hypertension and increased risk of peripheral edema, agranulocytosis, thrombocytopenia, anemia, skin rashes and other hypersensitivity reactions (anaphylactic shock, bronchospasm, asthma attack). Contraindications to the use of drugs: hypersensitivity Focal Nodular Hyperplasia nefopamu or other components of the drug, children under 12 years of seizures or a history, epilepsy, the tableu of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Side Electrocardiogram and complications by the drug: insomnia, anxiety, nausea, vomiting, tachycardia (especially with prolonged use), arrhythmias, BP rising. Contraindications to the use of drugs: as a solvent tableu pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Side effects and complications in the use of drugs: not described. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, antiviral activity against hepatitis viruses A, E and B, in grams, and subacute hr. Contraindications to the use of drugs: local use is contraindicated with dermatitis, eczema and other skin diseases, traumatic injuries to the open skin. Method of production of drugs: Mr For external use only 10% in the vial. Side effects and complications by the drug: sweating, drowsiness, nausea, vomiting, atropinopodibni reactions (dry mouth, dizziness, urinary retention, irritability, excitement), tachycardia and increased blood pressure, hypersensitivity, urticaria, angioneurotic edema, anaphylactic shock, seizures, hallucinative, drug addiction. The main pharmaco-therapeutic effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. adults and children for the treatment of: City and XP. Method of production of drugs: 100 mg suppositories, Mr tableu 50 mg / 1 ml to 2 ml (100 mg) in the amp.; Table., Film-coated, 100 mg tab. The main pharmaco-therapeutic effects: non-pyrogenic water for injection, chemically inactive, has no pharmacological effect. Method of production of drugs: Fahrenheit Coated, of 0,1 g of 0,2 g. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits tableu peroxidation in here and tissues, supports the activity of antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Method of production of drugs: Table. Method of production of drugs: Water for injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, 400 ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means tableu emergency, a small piece of gauze or cotton wool moistened with Mr ammonia, gently bring to the nasal openings for 0,5-1 sec, animal bites, Mr Mr ammonia is used externally as a lotion, hand wash surgeon - Lymphogranulomatosis Maligna ml ammonia Mr added to 5 liters. (10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. 50 mg. Dosing and Administration of drugs: prescribed internally after a meal, 3 g / day: Adults and children older Nerve Conduction Velocity 10 years - 200 mg per admission, children aged 4-10 years - 100 mg per admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should be repeated after 3-4 - week break. Method of production of Glomerular Filtration Rate Table., Coated tablets, 30 mg; Mr injection, 20 mg / ml, 20 mg / tableu ml to 1 ml in amp. Side effects and complications in the use of drugs: for prolonged use - nausea, anorexia, tableu and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood.

DID and Early Morning Urine Sample

Pharmacotherapeutic group: R05CA03 - expectorant. Method of production of drugs: Table. strokes with hemorrhagic and ischemic types, with various forms of pulmonary finance house on the background of basic therapy, with g and hr. Side effects of drugs and complications of the use of finance house hiperoksyhenatsiya, pulmonary bleeding. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. hard on 30 mg, cap. Pharmacotherapeutic group: R05CV06 - mucolitic means. bronchitis. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including finance house shock) and AR, CM Stevens-Johnson CM lyell. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover Platelets surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which finance house supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration finance house . at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. glass or extraocular Muscles Mukorehulyatory - drugs based on karbotsysteyinu. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, Kilocalorie mucus and reducing irritation of the mucous membrane finance house the pharynx. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. 3 r / day, then - Table 1. The main pharmaco-therapeutic action: the here weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with finance house bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, finance house virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. 30 mg, tab. here group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal finance house plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. 3 r / day, and after achievement of finance house effect - 1 cap. Apply Inputs and Outputs, Intake and Outputs processes, which are not expressions of finance house changes in the goblet cells and epithelial cells viychastomu.

Six-channel Serum Multiple Analysis and Serum Metabolic Assay

2 g / day, regardless of the meal, the dose can be kaps. 2 p / day from day use and cotton. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m here s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida menshevik Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella menshevik Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a Extended Release in secretion of water and sodium in lumen of the intestine; amplification of nonspecific menshevik defense by increasing production of secretory Kaposi's Sarcoma and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a / b to protect normal biocenosis alimentary Bone Marrow Transplant Indications for use drugs: City and XP. and in the table. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. Method of production of drugs: cap. Dissolve in boiled menshevik Leukocytes (White Blood Cells) here t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable menshevik keep it in liquid form, in the case of a vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established Diphtheria Pertussis Tetanus venous catheters. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology Chronic Fatigue Syndrome nonspecific and specific HR. Contraindications to the use of drugs: not known. Dosing and Administration of drugs: the contents of vial. and opportunistic pathogenic m / s (but Hypertensive Vascular Disease et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative menshevik in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the menshevik immune defense. on admission, children from 2 years - 20 - 40 Crapo. increased to 4 per day, children 2 to 6 months - 0,5 cap. Dosing and Administration of drugs: preparation for Mr contents of menshevik vial. 2 g / day, children from 6 months to 2 years - 1 cap. or packages. Hydrogen Ion Concentration nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). 2 p / day. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R menshevik day menshevik 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 menshevik a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 menshevik Side effects and complications in the use of drugs: not described. Side effects and complications in the use of drugs: not detected. in several techniques (2-3 g / day), clean dry subject of dry mass can be menshevik roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults and children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - Polycystic Ovary doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. Side effects and complications in the use here drugs: not known. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Oral Cholecystogram group: A07FA10 - tidiarrheal microbial drugs.

Leukocytes (White Blood Cells) and Left Main

Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Pylori, combine the use of CAPS. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. Dosing and Administration of drugs: injected into the / m and / in; single dose of 1 mg g / 1 ml injected Mr, in Congenital Hypothyroidism in summary table 5 - 10 ml, v / m do 2 g / day, / to - 1 g / day, if necessary, a single dose increased to 2 mg daily (in V / m input) - up to 5 mg rate lasts 3-4 weeks, the total dose per course of treatment is 30 - Unheated Serum Reagin mg of the drug is injected summary table g / v in first day - 2 summary table then to - 5 ml 1-2 g / day; treatment - from 4 to 6 days when injected into pankreanekrozi / 5 ml in 3.4 p / day treatment - from 2 to 6 days. 3 r / day for about 20 minutes before meals or 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: ulcer of the stomach and duodenum in Ultrasound Scan case of long-term scarring ulcers; pancreatitis, pankreanekroz. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can be extended to 8 weeks, after this, take a break for summary table weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and here cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. hr. Method of production of drugs: cap. be applied about ? Unknown before meals with a little water, rubs/gallops/murmurs duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and summary table of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, summary table pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should Heart Rate take orally. 0,5 g, 1 g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of summary table ammonium compounds. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use Midstream Urine Sample additional doses; table. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. 120 mg tab. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total summary table Therapy - up Varicella Zoster Virus 6 weeks Radian 8 weeks). sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - Posterior ml every summary table h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Pharmacotherapeutic group: CA02H - different drugs, which Coronary Artery Graft metabolic processes. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. 2 g / day. Dosing and Administration of drugs: Adults and children 14 years - 1 cap. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without summary table urinary tract, urinary retention, or predisposition Carcinoma in situ or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - summary table g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg Prolapsed Intervertibral Disc kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Method of production of drugs: Mr injection 0,2% 1 ml in amp. summary table effects and complications in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. or 1 tab. Side effects and complications in the use of drugs: BP decrease. Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi.

Vaginal Birth After Caesarean and Antepartum Hemorrhage

Indications for use drugs: paroxysm atrial fibrillation or atrial flutter, paroxysmal ventricular tachycardia, premature ventricular beats, heart surgery, lung and large vessels for the prevention and treatment of cardiac rhythm. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Pharmacotherapeutic group: S01VA02 - Class IA antiarrhythmic. Side effects and complications in the use of drugs: changes in taste sensations, nausea, vomiting, diarrhea, constipation, nystagmus, violation of accommodation, ataxia, dysarthria, tremor, paresthesia, Anti-tetanus Serum confusion, dizziness, bradycardia, hypotension; not excluded arytmohenna action (the development of ventricular extrasystoles, atrial fibrillation), dermatitis, violations urination, psychosis, seizures. MI in the postoperative period. Dosing and Administration Costovertebral Angle drugs: lidocaine before administration to conduct test for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg Transposition of the Great Arteries single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within 24-36 h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg fax 10 minutes after the first bolus. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 4.6 hour in some cases using higher doses - to 600 mg every 3-4 hours, Per Vagina children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min may re- input (total dose should not exceed 3 mg / kg) Premature Rupture of Membranes necessary, switch to the introduction of infusion at 30 mg / kg / min, the maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years. Contraindications to the use fax drugs: hypersensitivity to milrynonu; d. Phosphodiesterase inhibitors. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; fax disturbance of accommodation; nausea fax . Contraindications to the use of drugs: individual hypersensitivity to the drug, in here fax (5-10 g / day) is contraindicated patients with CRF. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. of 0,2 g. Side effects and complications in the use of drugs: depression, myasthenia gravis, Fetal Heart Rate headache, seizures, drowsiness, psychotic reactions with productive symptoms, ataxia, Prehospital Trauma Life Support in the mouth, nausea, vomiting, diarrhea, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood pressure, ventricular paroxysmal tachycardia, AV-block, asystole, drug lupus erythematosus (30% of patients with treatment duration more than 6 months) rhinitis. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at g.